Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronidase via LADD for Scleroderma-induced Microstomia
NCT05995626Phase 1Completed
- Sponsor
- University of Nebraska
- Start
- Mar 2024
- Primary completion
- Sep 2024
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of hyaluronidase in microstomia, sponsored by University of Nebraska. Primary endpoint: Difference in Interincisal Distance at 6 months. Started Mar 2024; status: completed.
02
Drugs
hyaluronidase
03
Conditions
microstomia
Beyond the preview
Go deeper on NCT05995626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05995626.